Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Ormat Technologies | ORA | Mar 31, 2025 | 70.77 | +0.28 |
Orrstown Financial Services | ORRF | Mar 31, 2025 | 30.01 | +0.03 |
Orthofix Medical | OFIX | Mar 31, 2025 | 16.31 | +1.56 |
OrthoPediatrics | KIDS | Mar 31, 2025 | 24.63 | -0.44 |
Oruka Therapeutics | ORKA | Mar 31, 2025 | 10.26 | -17.92 |
OS Therapies | OSTX | Mar 31, 2025 | 1.54 | -4.94 |
Oscar Health A | OSCR | Mar 31, 2025 | 13.11 | -1.43 |
Oshkosh | OSK | Mar 31, 2025 | 94.08 | -0.24 |
OSI Systems | OSIS | Mar 31, 2025 | 194.34 | +0.53 |
Osisko Development | ODV | Mar 31, 2025 | 1.49 | 0.00 |
Osisko Gold Royalties | OR | Mar 31, 2025 | 21.12 | +0.96 |
OSR Holdings | OSRH | Mar 31, 2025 | 1.88 | 0.00 |
Ostin Technology Group | OST | Mar 31, 2025 | 1.52 | -12.14 |
Otis Worldwide | OTIS | Mar 31, 2025 | 103.20 | +1.07 |
Otter Tail | OTTR | Mar 31, 2025 | 80.37 | -0.45 |
Ouster | OUST | Mar 31, 2025 | 8.98 | -5.87 |
Outbrain | OB | Mar 31, 2025 | 3.73 | -1.84 |
Outfront Media | OUT | Mar 31, 2025 | 16.14 | -0.86 |
Outlook Therapeutics | OTLK | Mar 31, 2025 | 1.22 | -7.58 |
Outset Medical | OM | Mar 31, 2025 | 11.06 | -12.08 |
Ovid Therapeutics | OVID | Mar 31, 2025 | 0.31 | -10.89 |
Ovintiv | OVV | Mar 31, 2025 | 42.80 | +1.37 |
Owens & Minor | OMI | Mar 31, 2025 | 9.03 | +5.24 |
Owens Corning | OC | Mar 31, 2025 | 142.82 | +0.13 |
Owlet A | OWLT | Mar 31, 2025 | 3.68 | +2.79 |
Oxbridge Re | OXBR | Mar 31, 2025 | 1.89 | -6.44 |
Oxford Industries | OXM | Mar 31, 2025 | 58.67 | -0.49 |
Oxford Lane Capital | OXLC | Mar 31, 2025 | 4.72 | +1.51 |
Oxford Lane Capital 2027 Pref | OXLCP | Mar 31, 2025 | 24.17 | -0.04 |
Oxford Square Capital | OXSQ | Mar 31, 2025 | 2.61 | +1.95 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.